DONATE-Pilot Study on ICU Management of Deceased Organ Donors
NCT ID: NCT02902783
Last Updated: 2018-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
177 participants
OBSERVATIONAL
2015-09-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Endotoxin Activity in Patients With ECMO
NCT03978728
Usefulness of an Ultraportative Ultrasound Device in the Management of Intra Hospital Emergencies
NCT02967809
Predictors of Apnea and Prediction of Time to Death in Donation After Cardiac Death
NCT02430961
AFrican Resuscitation Ultrasound In Critically-ill Adults
NCT02794909
Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department
NCT01444768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main objectives of the DONATE-Pilot reflect the objectives of the national study which correspond to the steps in developing a platform for future clinical trials.
1. Form research teams at participating ICUs that will include an ICU physician-researcher, a local organ donation champion, ICU research coordinators and (in a limited role) a local coordinator from the provincial Organ Donation Organization (ODO);
2. Observe, record, and describe ICU practices in deceased donor care (e.g., donor resuscitation, organ suitability assessments, death declaration) which are likely to vary by site, region and province and will be very important to inform clinical care protocols for future RCTs.
3. Engage and work with ODOs from each province to foster data sharing and develop procedures to enhance efficiency in future RCTs.
4. Investigate the comparative effectiveness of various ICU interventions in deceased donor care (e.g. the potential for hormonal therapies to improve transplant rates, the potential of heparin therapy to improve peri-operative graft function);
5. Produce specific knowledge translation tools that will serve in the future as both clinical tools to enhance ICU care and research tools to facilitate future RCTs.
As part of the DONATE-Pilot we also aim to assess feasibility. Specifically the objectives are to:
1. Refine data collection procedures for deceased donors in ICU;
2. Estimate time requirements for data collection;
3. Develop efficient links to post-transplantation data and;
4. Share data as it accrues with clinicians.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Consented deceased organ donors
Data will be collected on deceased donors, declared by neurological determination of death (DND) and by circulatory determination of death (DCD).
Data Collection
Data collection relevant to this study will be obtained by observation and review of hospital charts. Limited data will be obtained through relevant organ donation organizations (ODOs).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data Collection
Data collection relevant to this study will be obtained by observation and review of hospital charts. Limited data will be obtained through relevant organ donation organizations (ODOs).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consented deceased organ donors (DND and DCD)
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Critical Care Trials Group
OTHER
Canadian National Transplant Research Program
OTHER
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meade Maureen, MD, MSc
Role: STUDY_DIRECTOR
McMaster University
Frederick D'Aragon, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
Université de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamilton General Hospital
Hamilton, Ontario, Canada
Centre de recherche CHUS
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
D'Aragon F, Cook D, Dhanani S, Ribic C, Burns KEA, Akhtar A, Hand L, Arseneau E, Cupido C, Whittigham H, Healey A, Frenette AJ, Lamontagne F, Meade MO; Canadian Critical Care Trials Group and the Canadian National Transplant Research Program. Hamilton-DONATE: a city-wide pilot observational study of the ICU management of deceased organ donors. Can J Anaesth. 2018 Oct;65(10):1110-1119. doi: 10.1007/s12630-018-1179-y. Epub 2018 Jul 9.
Related Links
Access external resources that provide additional context or updates about the study.
DONATE Reseearch Progam Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DONATE-Pilot 14-803
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.